IAXO-102 is primarily utilized in research and development within the field of oncology. It functions as a potent inhibitor targeting specific pathways involved in cancer cell proliferation and survival. Researchers employ this compound to study its effects on tumor growth and to explore its potential as a therapeutic agent in various cancer types. Its application extends to preclinical studies, where it is used to evaluate efficacy, safety, and mechanism of action in animal models. Additionally, IAXO-102 serves as a valuable tool in understanding cellular signaling mechanisms, aiding in the discovery of novel drug targets for cancer treatment.